You searched for "neovascular"
Addressing medical risk factors for diabetes and understanding the new systemic treatments
1 February 2014
| Samantha S Mann
As global diabetes figures continue to rise, the importance of reducing the burden of macrovascular and microvascular complications of diabetes has never been so great. By 2025 it is estimated that five million people in the UK will have diabetes...
OCT angiography metrics in children
3 June 2021
| Fiona Rowe (Prof)
|
Paediatric Ophthalmology / Strabismus
This prospective study aimed to quantify the vessel density of both the macular and optic nerve and foveal avascular zone (FAZ) values in 92 normal eyes of 92 children (42 boys, 50 girls) aged 13.4 ±2.65 years (seven to 18)....
Licence to save: a UK survey of anti-VEGF use for the eye
1 February 2017
| Sofia Rokerya
|
Retina / Uvea / Vitreous
This comment article highlights the controversy that exists in the choice for anti-VEGF drugs used for treatment of macular oedema and wet age-related macular degeneration (AMD). Two existing licensed drugs for macular oedema are ranibizumab (Lucentis) and aflibercept (Eylea). A...
Haag-Streit announces “Slit Lamp Imaging Competition 2024” winners
18 October 2024
|
opportunities, slit lamp, imaging, competition, awards, haag-streit, SLIC2024, 2024
Haag-Streit UK (HS-UK), the leading manufacturer and distributor of gold-standard diagnostic and surgical devices and instruments for ophthalmologists, optometrists, and orthoptists, is pleased to announce the results of Haag-Streit's 'Slit Lamp Imaging Competition 2024'. Utpal Sarkar, from Disha Eye Hospitals,...
Third nerve palsy
1 August 2017
|
Ophthalmology, Neuro-Ophthalmology
Case scenarios A 71-year-old female presented to a nearby eye emergency unit with two days history of partial ptosis in her left eye with diplopia. She saw her GP earlier that day and he asked her to go to the...
Corporate M&A pace gathers momentum
1 October 2019
| Rod McNeil
|
AMD, Cataract and Refractive, Cornea / External Eye Disease, Emergency Ophthalmology, Genetics, Glaucoma, Imaging, Neuro-Ophthalmology, Ocular Pathology and Oncology, Oculoplastics, Ophthalmology, Optometry, Orbit, Paediatric Ophthalmology / Strabismus, Retina / Uvea / Vitreous
Intensifying franchise competition, maturing product development pipelines and looming loss of exclusivity spur renewed merger and acquisition (M&A) activity in the ophthalmics sector. Rod McNeil reviews recent deals and related strategic developments. AbbVie to acquire Allergan in $63 billion mega-combination,...
Eye Capacity: clinical need should drive ophthalmic service provision
1 February 2014
| Rod McNeil
Almost two million people in the UK suffer sight loss, a number forecast to double over coming decades. Major causes of blindness are age-related macular degeneration (AMD), glaucoma, diabetic retinopathy, cataract and uncorrected refractive error. Prevalence of these sight-threatening conditions...
Belfast briefing: Retina Day roundup from the RCOphth 2024 Annual Congress
2 August 2024
| Rod McNeil
|
Ophthalmology
Belfast hosted this year’s Royal College of Ophthalmologists’ (RCOphth) Annual Congress, a meeting dedicated to sharing advances, knowledge and clinical practice points in ophthalmic care. This article summarises selected talks by medical and surgical retina specialists during the Retina Subspecialty...
21st Century retinal laser treatment in the anti-VEGF era
1 June 2017
| John Awad, Prasad Rao
|
Retina / Uvea / Vitreous
In today’s world, macular laser treatment has a vital role in the treatment of diabetic macular oedema (DMO). DMO is one of the most common causes of visual impairment. Despite expensive intravitreal treatment courses of anti-VEGF, many will agree that...
The role of injection assistant devices in establishing a nurse-led AMD service
1 April 2018
| Hani Hasan
|
Retina / Uvea / Vitreous
The author shares his experience of setting up a nurse-led service to deliver anti-VEGF intravitreal injections and how injection assistant devices supported training. Age-related macular degeneration (AMD) has become a leading cause of irreversible blindness [1]. It is estimated that...
More sensitive visual acuity test for age-related macular degeneration
1 October 2016
| Roger S Anderson (Prof), Nilpa Shah
|
Retina / Uvea / Vitreous
Age-related macular degeneration (AMD) is the leading cause of blindness in the developed world. Primarily associated with ageing, genetic factors and lifestyle choices such as smoking also play a contributory role. Patients with early AMD, characterised by the development of...